{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:12:05Z","timestamp":1790712725730,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"1186","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This systematic review describes the spectrum, distribution, and etiologies of non\u2011target [68Ga]Ga-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-1-Nal\u00b3-octreotide ([68Ga]Ga\u2011DOTANOC)\u2011avid lesions proven by histopathology or follow\u2011up to be unrelated to normal biodistribution or the primary somatostatin receptor\u2011expressing disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Web of Science, and Scopus databases were utilized to conduct a systematic search and were updated until May 31, 2025. Three authors independently screened the titles and abstracts of the retrieved articles and selected the articles on the basis of the inclusion and exclusion criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventy-six eligible studies encompassing 542 patients reported 799 non-target [68Ga]Ga-DOTANOC-avid findings. Nononcologic causes accounted for the majority (59.6%), with malignant oncologic and benign tumorous etiologies accounting for 30.2% and 10.3%, respectively. The abdomen was the most common anatomical site (38%), followed by the thorax (21.6%), head\/neck (18.1%), and musculoskeletal system (13.1%), whereas pelvic involvement was least common (9%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Abdominal non-target [68Ga]Ga-DOTANOC-avid findings represent a major interpretive challenge in [68Ga]Ga-DOTANOC PET\/CT, as these findings often overlap with NET-predominant regions. Recognition of these patterns can increase diagnostic accuracy and support broader clinical integration of [68Ga]Ga-DOTANOC beyond its conventional utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Advances in knowledge<\/jats:title>\n                    <jats:p>This systematic review clarifies anatomy-based and etiology-based non-target findings that can be encountered in [68Ga]Ga-DOTANOC PET imaging. Non-target findings with [68Ga]Ga-DOTANOC, while challenging, may expand its use beyond NETs and meningiomas, opening new diagnostic avenues.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjr\/tqag181","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T04:24:45Z","timestamp":1786163085000},"page":"2093-2104","source":"Crossref","is-referenced-by-count":0,"title":["First systematic mapping of non-target [68Ga]Ga-DOTANOC uptake across anatomical sites and etiologies"],"prefix":"10.1093","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6913-677X","authenticated-orcid":false,"given":"Dhuha","family":"Al-Adhami","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Baghdad Radiotherapy and Nuclear Medicine Hospital, Bab Al-Muadham , Baghdad 10047, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2009-5110","authenticated-orcid":false,"given":"Ahmed Saad","family":"Abdlkadir","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Baghdad Radiotherapy and Nuclear Medicine Hospital, Bab Al-Muadham , Baghdad 10047, Iraq"},{"name":"Department of Oral and Maxillofacial Surgery, Al-Hikma University, College of Dentistry , Baghdad 100015, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuha Saad","family":"Abdlkadir","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Al-Hikma University, College of Dentistry , Baghdad 100015, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Ruzzeh","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT, King Hussein Cancer Center (KHCC) , Amman 11941,","place":["Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwah","family":"Abdulrahman","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT, King Hussein Cancer Center (KHCC) , Amman 11941,","place":["Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa","family":"Mohamad","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, King Hussein Cancer Center (KHCC) , Amman 11941,","place":["Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"Abu Sheikha","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, King Hussein Cancer Center (KHCC) , Amman 11941,","place":["Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-1359","authenticated-orcid":false,"given":"Hongcheng","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Zhongshan Hospital, Fudan University , Shanghai 200433,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalevi","family":"Kairemo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Texas, MD Anderson Cancer Center , Houston, TX 77094,","place":["United States"]},{"name":"Department of Molecular Radiotherapy and Nuclear Medicine, International Comprehensive Cancer Center Docrates , Helsinki 00180,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Al-Ibraheem","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT, King Hussein Cancer Center (KHCC) , Amman 11941,","place":["Jordan"]},{"name":"School of Medicine, University of Jordan , Amman 11942,","place":["Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"2026092915464052800_tqag181-B1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/cancers15020513","article-title":"Prospective multicentric assessment of 68Ga-DOTANOC PET\/CT in grade 1-2 GEP-NET","volume":"15","author":"Lugat","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026092915464052800_tqag181-B2","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.3390\/cancers14122925","article-title":"The role of [(68)Ga]Ga-DOTA-SSTR PET radiotracers in brain tumors: a systematic review of the literature and ongoing clinical trials","volume":"14","author":"Palmisciano","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026092915464052800_tqag181-B3","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s00259-004-1697-4","article-title":"68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5","volume":"32","author":"Wild","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026092915464052800_tqag181-B4","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.2217\/fon.14.139","article-title":"Pet tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature","volume":"10","author":"Johnbeck","year":"2014","journal-title":"Future Oncol"},{"key":"2026092915464052800_tqag181-B5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000472717","article-title":"68Gallium DOTANOC-PET imaging in lung carcinoids: impact on patients\u2019 management","volume":"106","author":"Lamarca","year":"2018","journal-title":"Neuroendocrinology"},{"key":"2026092915464052800_tqag181-B6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00259-013-2598-1","article-title":"Diagnostic accuracy of 68Ga-DOTANOC PET\/CT imaging in pheochromocytoma","volume":"41","author":"Sharma","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026092915464052800_tqag181-B7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.21037\/jgo.2016.01.06","article-title":"Ga-68 DOTANOC PET\/CT imaging in detection of primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India","volume":"7","author":"Pruthi","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"2026092915464052800_tqag181-B8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2967\/jnumed.124.269215","article-title":"Consensus nomenclature for radionuclide therapy: initial recommendations from nuclear medicine global initiative","volume":"66","author":"Al-Ibraheem","year":"2025","journal-title":"J Nucl Med"},{"key":"2026092915464052800_tqag181-B9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1053\/j.semnuclmed.2020.04.001","article-title":"Evidence base for the use of PRRT","volume":"50","author":"Buscombe","year":"2020","journal-title":"Semin Nucl Med"},{"key":"2026092915464052800_tqag181-B10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2217\/ije.15.5","article-title":"Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors: current state and future perspectives","volume":"2","author":"Baum","year":"2015","journal-title":"Int J Endo Oncol"},{"key":"2026092915464052800_tqag181-B11","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1007\/s00259-011-1989-4","article-title":"68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET","volume":"39","author":"Ambrosini","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026092915464052800_tqag181-B12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1053\/j.semnuclmed.2024.02.003","article-title":"Radiotheranostics global market and future developments","volume":"54","author":"Al-Ibraheem","year":"2024","journal-title":"Semin Nucl Med"},{"key":"2026092915464052800_tqag181-B13","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026092915464052800_tqag181-B14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"2026092915464052800_tqag181-B15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jclinepi.2013.08.003","article-title":"The CARE guidelines: consensus-based clinical case report guideline development","volume":"67","author":"Gagnier","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"2026092915464052800_tqag181-B16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid Based Med"},{"key":"2026092915464052800_tqag181-B17","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3390\/cancers16091728","article-title":"FDG-PET in chimeric antigen receptor T-cell (CAR T-cell) therapy toxicity: a systematic review","volume":"16","author":"Al-Ibraheem","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026092915464052800_tqag181-B18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3978\/j.issn.2305-5839.2015.06.10","article-title":"Somatostatin receptors over-expression in castration resistant prostate cancer detected by PET\/CT: preliminary report of in six patients","volume":"3","author":"Savelli","year":"2015","journal-title":"Ann Transl Med"},{"key":"2026092915464052800_tqag181-B19","doi-asserted-by":"publisher","first-page":"E76","DOI":"10.1002\/hed.24164","article-title":"68Ga-DOTA-peptide: a novel molecular biomarker for nasopharyngeal carcinoma","volume":"38","author":"Khor","year":"2016","journal-title":"Head Neck"},{"key":"2026092915464052800_tqag181-B20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/mnm.0000000000001362","article-title":"Clinical utility of Ga68 DOTANOC PET\/CT imaging in juvenile nasal angiofibroma and the PARIS protocol: a preliminary report","volume":"42","author":"Thakar","year":"2021","journal-title":"Nucl Med Commun"},{"key":"2026092915464052800_tqag181-B21","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s00259-014-2723-9","article-title":"Prospective evaluation of 68Ga-DOTANOC PET-CT in differentiated thyroid cancer patients with raised thyroglobulin and negative 131I-whole body scan: comparison with 18F-FDG PET-CT","volume":"41","author":"Kundu","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026092915464052800_tqag181-B22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/mnm.0000000000001155","article-title":"Differentiating dural metastases from meningioma: role of 68Ga DOTA-NOC PET\/CT","volume":"41","author":"Purandare","year":"2020","journal-title":"Nucl Med Commun"},{"key":"2026092915464052800_tqag181-B23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/0284186X.2017.1342864","article-title":"Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at 68Ga-DOTANOC PET\/CT imaging","volume":"57","author":"Ruuska","year":"2018","journal-title":"Acta Oncol"},{"key":"2026092915464052800_tqag181-B24","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/mnm.0000000000001532","article-title":"Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 68Ga-DOTANOC PET\/computed tomography in articular manifestation of rheumatoid arthritis","volume":"43","author":"Shamim","year":"2022","journal-title":"Nucl Med Commun"},{"key":"2026092915464052800_tqag181-B25","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2214\/ajr.14.12588","article-title":"Neuroendocrine tumor imaging with 68Ga-DOTA-NOC: physiologic and benign variants","volume":"203","author":"Kagna","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"2026092915464052800_tqag181-B26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2967\/jnumed.112.111724","article-title":"Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET\/CT within patients with gastroenteropancreatic neuroendocrine tumors","volume":"54","author":"Wild","year":"2013","journal-title":"J Nucl Med"},{"key":"2026092915464052800_tqag181-B27","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.3390\/cancers14143541","article-title":"[68Ga]Ga-DOTANOC uptake at pancreatic head\/uncinate process: is it a persistent diagnostic pitfall over time?","volume":"14","author":"Tabacchi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026092915464052800_tqag181-B28","doi-asserted-by":"publisher","first-page":"886","DOI":"10.2967\/jnumed.111.088328","article-title":"Incidence of increased 68Ga-DOTANOC uptake in the pancreatic head in a large series of extrapancreatic NET patients studied with sequential PET\/CT","volume":"52","author":"Castellucci","year":"2011","journal-title":"J Nucl Med"},{"key":"2026092915464052800_tqag181-B29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/rlu.0000000000000601","article-title":"Intrapancreatic accessory spleen detected by 68Ga DOTANOC PET\/CT and 99mTc-colloid SPECT\/CT scintigraphy","volume":"40","author":"Collarino","year":"2015","journal-title":"Clin Nucl Med"},{"key":"2026092915464052800_tqag181-B30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/wjnm.WJNM_1_17","article-title":"Usefulness of splenic scintigraphy in differentiating splenosis and malignancy on gallium 68 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-NaI3-octreotide","volume":"17","author":"Van Hecke","year":"2018","journal-title":"World J Nucl Med"},{"key":"2026092915464052800_tqag181-B31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/mpa.0000000000000728","article-title":"The accessory spleen is an important pitfall of 68Ga-DOTANOC PET\/CT in the workup for pancreatic neuroendocrine neoplasm","volume":"46","author":"Rufini","year":"2017","journal-title":"Pancreas"},{"key":"2026092915464052800_tqag181-B32","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/MNM.0b013e328364eaab","article-title":"Evaluation and comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-NOC PET\/CT imaging in well-differentiated thyroid cancer","volume":"34","author":"Ocak","year":"2013","journal-title":"Nucl Med Commun"},{"key":"2026092915464052800_tqag181-B33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer 68Ga-DOTANOC PET\/CT and 18F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res"},{"key":"2026092915464052800_tqag181-B34","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.2967\/jnumed.110.079962","article-title":"68Ga-DOTANOC PET\/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results","volume":"51","author":"Ambrosini","year":"2010","journal-title":"J Nucl Med"},{"key":"2026092915464052800_tqag181-B35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijcard.2015.05.073","article-title":"Imaging of myocardial inflammation with somatostatin receptor based PET\/CT-a comparison to cardiac MRI","volume":"194","author":"Lapa","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026092915464052800_tqag181-B36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s40336-020-00390-0","article-title":"FDG PET\/CT versus somatostatin receptor PET\/CT in TENIS syndrome: a systematic review and meta-analysis","volume":"8","author":"Mourato","year":"2020","journal-title":"Clin Transl Imaging"},{"key":"2026092915464052800_tqag181-B37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13550-015-0106-2","article-title":"Somatostatin receptor subtype 2 in high-grade gliomas: PET\/CT with 68Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy","volume":"5","author":"Kiviniemi","year":"2015","journal-title":"EJNMMI Res"},{"key":"2026092915464052800_tqag181-B38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.22038\/aojnmb.2020.44324.1297","article-title":"Demonstration of focal physiologic in-vivo somatostatin receptor expression in the caput epididymis of the testes on (68)Ga-DOTANOC PET\/CT and (177)Lu-DOTATATE post-therapy whole body scintigraphy","volume":"8","author":"Parihar","year":"2020","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"2026092915464052800_tqag181-B39","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1097\/rlu.0000000000003850","article-title":"Incidentally detected high SSTR expression in uterine leiomyoma on DOTANOC PET\/CT","volume":"47","author":"Datta Gupta","year":"2022","journal-title":"Clin Nucl Med"},{"key":"2026092915464052800_tqag181-B40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/rlu.0000000000002013","article-title":"Adenocarcinoma prostate with neuroendocrine differentiation: potential utility of 18F-FDG PET\/CT and 68Ga-DOTANOC PET\/CT over 68Ga-PSMA PET\/CT","volume":"43","author":"Parida","year":"2018","journal-title":"Clin Nucl Med"},{"key":"2026092915464052800_tqag181-B41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/ijnm.IJNM_127_20","article-title":"Obstructive jaundice: an unusual presentation of neuroendocrine differentiation in prostatic adenocarcinoma","volume":"36","author":"Santhosh","year":"2021","journal-title":"Indian J Nucl Med"},{"key":"2026092915464052800_tqag181-B42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.14740\/wjon739w","article-title":"Neuroendocrine differentiation of prostate cancer metastases evidenced \u201cin vivo\u201d by (68)Ga-DOTANOC PET\/CT: two cases","volume":"5","author":"Savelli","year":"2014","journal-title":"World J Oncol"},{"key":"2026092915464052800_tqag181-B43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.23736\/s1824-4785.25.03638-6","article-title":"PET imaging and radionuclide therapy in neuroendocrine prostate cancer: a systematic review","volume":"69","author":"Abdlkadir","year":"2025","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"2026092915464052800_tqag181-B44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.5334\/jbr-btr.903","article-title":"Paget\u2019s disease mimicking bone metastasis in a patient with neuroendocrine tumor on (68)Ga-DOTANOC PET\/CT","volume":"100","author":"Gezer","year":"2016","journal-title":"J Belg Soc Radiol"},{"key":"2026092915464052800_tqag181-B45","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s40336-022-00519-3","article-title":"SARS-CoV-2 vaccination site as possible pitfall on somatostatin receptor imaging","volume":"10","author":"Kolade","year":"2022","journal-title":"Clin Transl Imaging"},{"key":"2026092915464052800_tqag181-B46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/0972-3919.172344","article-title":"Diagnostic importance of contrast enhanced 18F-fluorodeoxyglucose positron emission computed tomography in patients with tumor induced osteomalacia: our experience","volume":"31","author":"Jain","year":"2016","journal-title":"Indian J Nucl Med"},{"key":"2026092915464052800_tqag181-B47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1359\/jbmr.060909","article-title":"Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography","volume":"22","author":"Hesse","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2026092915464052800_tqag181-B48","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/mnm.0000000000001987","article-title":"Diagnostic pitfalls in [68Ga]Ga-DOTATATE PET\/CT imaging: a systematic review","volume":"46","author":"Abdlkadir","year":"2025","journal-title":"Nucl Med Commun"},{"key":"2026092915464052800_tqag181-B49","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4274\/mirt.galenos.2025.44452","article-title":"False positive findings of (68)Ga-DOTATOC PET\/CT: a systematic review","volume":"34","author":"Al-Adhami","year":"2025","journal-title":"Mol Imaging Radionucl Ther"}],"container-title":["British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/advance-article-pdf\/doi\/10.1093\/bjr\/tqag181\/70543839\/tqag181.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/99\/1186\/2093\/70543839\/tqag181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/99\/1186\/2093\/70543839\/tqag181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:46:50Z","timestamp":1790711210000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/99\/1186\/2093\/8756590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":49,"journal-issue":{"issue":"1186","published-online":{"date-parts":[[2026,8,7]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bjr\/tqag181","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,8,7]]}}}